These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25027535)

  • 41. Reduction of clozapine-induced hypersalivation by pirenzepine is safe.
    Schneider B; Weigmann H; Hiemke C; Weber B; Fritze J
    Pharmacopsychiatry; 2004 Mar; 37(2):43-5. PubMed ID: 15048609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In brief: Glycopyrrolate oral solution for sialorrhea.
    Med Lett Drugs Ther; 2011 Jan; 53(1355):4. PubMed ID: 21212745
    [No Abstract]   [Full Text] [Related]  

  • 43. Current treatment strategies for clozapine-induced sialorrhea.
    Bird AM; Smith TL; Walton AE
    Ann Pharmacother; 2011 May; 45(5):667-75. PubMed ID: 21540404
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clozapine-induced sialorrhea alleviated by bupropion--a case report.
    Stern RG; Bellucci D; Cursi-Vogel N; Hughley J; Elangovan N
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1578-80. PubMed ID: 19800381
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clozapine-induced parotitis: a case study].
    Gouzien C; Valiamé A; Misdrahi D
    Encephale; 2014 Feb; 40(1):81-5. PubMed ID: 23809173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial.
    Arbouw ME; Movig KL; Koopmann M; Poels PJ; Guchelaar HJ; Egberts TC; Neef C; van Vugt JP
    Neurology; 2010 Apr; 74(15):1203-7. PubMed ID: 20385892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The clozapine-induced hypersalivation and its treatment].
    Soler Roibal MA; Oca Bravo L; Montejo Iglesias LM
    Actas Esp Psiquiatr; 1999; 27(6):408-11. PubMed ID: 10611565
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amisulpride treatment for clozapine-induced sialorrhea.
    Praharaj SK; Sarkar S; Sinha VK
    J Clin Psychopharmacol; 2009 Apr; 29(2):189-90. PubMed ID: 19512987
    [No Abstract]   [Full Text] [Related]  

  • 49. Clozapine-induced hypersalivation and the alpha 2 adrenoceptor.
    Corrigan FM; MacDonald S; Reynolds GP
    Br J Psychiatry; 1995 Sep; 167(3):412. PubMed ID: 7496663
    [No Abstract]   [Full Text] [Related]  

  • 50. Evaluation and Comparison of the Effectiveness of Atropine Eye Drops, Ipratropium Bromide Nasal Spray, and Amitriptyline Tablet in the Management of Clozapine-Associated Sialorrhea in Patients With Refractory Schizophrenia: A Randomized Clinical Trial.
    Mohammad-Gholizad F; Karimzadeh I; Moghimi-Sarani E; Arshadi M; Mortazavi N
    J Clin Psychopharmacol; 2024 Jan-Feb 01; 44(1):9-15. PubMed ID: 38100776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clozapine-induced hypersalivation.
    Davydov L; Botts SR
    Ann Pharmacother; 2000 May; 34(5):662-5. PubMed ID: 10852096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of drooling: 10 years after the Consortium on Drooling, 1990.
    Blasco PA
    Dev Med Child Neurol; 2002 Nov; 44(11):778-81. PubMed ID: 12418620
    [No Abstract]   [Full Text] [Related]  

  • 53. Scolpolamine patch for clozapine-induced sialorrhea.
    Gaftanyuk O; Trestman RL
    Psychiatr Serv; 2004 Mar; 55(3):318. PubMed ID: 15001737
    [No Abstract]   [Full Text] [Related]  

  • 54. A systematic chart review of pharmacological interventions in patients with clozapine-induced hypersalivation.
    Mutlu E; Özçelik Eroğlu E; Coşkun FÖ; Koçyiğit D; Canpolat İKN; Avcı H; Ertuğrul A; Anıl Yağcıoğlu AE
    Schizophr Res; 2024 Jun; 268():138-144. PubMed ID: 37597972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of clozapine-induced hypersalivation with ipratropium bromide: a randomized, double-blind, placebo-controlled crossover study.
    Sockalingam S; Shammi C; Remington G
    J Clin Psychiatry; 2009 Aug; 70(8):1114-9. PubMed ID: 19758522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug usage to alleviate the adverse effects of clozapine.
    McKean A; Vella-Brincat J
    Australas Psychiatry; 2011 Apr; 19(2):175. PubMed ID: 21443398
    [No Abstract]   [Full Text] [Related]  

  • 57. Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration.
    Yusufi B; Mukherjee S; Flanagan R; Paton C; Dunn G; Page E; Barnes TR
    Int Clin Psychopharmacol; 2007 Jul; 22(4):238-43. PubMed ID: 17519648
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sulpiride addition for the treatment of clozapine-induced hypersalivation: preliminary study.
    Kreinin A; Epshtein S; Sheinkman A; Tell E
    Isr J Psychiatry Relat Sci; 2005; 42(1):61-3. PubMed ID: 16134408
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aspiration Pneumonia Due to Clozapine-Induced Sialorrhea.
    Saenger RC; Finch TH; Francois D
    Clin Schizophr Relat Psychoses; 2016; 9(4):170-2. PubMed ID: 23773887
    [No Abstract]   [Full Text] [Related]  

  • 60. Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.
    Croissant B; Hermann D; Olbrich R
    Pharmacopsychiatry; 2005 Jan; 38(1):38-9. PubMed ID: 15706466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.